Sponsor or institution
Clinical trials and research at Women's Hospital School Of Medicine Zhejiang University
As of November 12, 2026, Find a Trial lists 24 clinical trials run by Women's Hospital School Of Medicine Zhejiang University that are recruiting, at sites in 3 countries (most in China (24), Rwanda (1), Hong Kong (1)). 2 were first registered in the last 30 days. By phase: Phase 2 (3), Phase 3 (1), Early Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 24Clinical trials
- 2New in 30 days
- 3Countries
Newest trials
All recruiting trials (24)
-
Using LC-MS/MS to profile androgens for PCOS diagnosis
This study tests whether LC-MS/MS measurement of androgen profiles can help diagnose PCOS in women compared with healthy controls.
-
Comparison of operative hysteroscopy vs vacuum aspiration for first-trimester termination with intrauterine adhesions
In people with early pregnancy and intrauterine adhesions, this study tests whether hysteroscopy with adhesiolysis plus vacuum aspiration is safer or more effective than vacuum aspiration alone for terminating the pregnancy.
-
Treatment outcomes after cesarean scar pregnancy surgeries
This study tests different surgical options for treating cesarean scar pregnancy to see how they affect recovery and future pregnancy outcomes.
-
Whole-genome sequencing in fetuses with unexplained ultrasound findings
Doctors will test whether whole-genome sequencing can find genetic reasons for fetal abnormalities when standard tests are negative, and how the results might influence pregnancy decisions.
-
Newborn whole-genome sequencing and genetic disease risk in pregnancy and early life
This project will collect small biological samples from pregnant families and newborns to try whole-genome sequencing and other multi-omics tests to find genetic disease risks.
-
Camrelizumab plus chemotherapy as adjuvant treatment for node-positive stage IIICp cervical cancer
This trial tests whether adding camrelizumab to chemotherapy after radical surgery helps people with PD-L1–positive, node-positive (FIGO2018 IIIC1p/IIIC2p) cervical cancer.
-
Prenatal cfDNA Screening in Pregnancies with Diverse Genetic Risk Profiles
This study tests two cfDNA approaches from a single maternal blood sample to see if they can detect a wide range of fetal genetic conditions in pregnant people with various risk factors.
-
Inducing labor at 39 weeks versus later induction or waiting in low‑risk pregnancies in China.
This study will test whether inducing labor at 39 weeks, compared with inducing at 41 weeks or waiting, reduces cesarean deliveries and improves outcomes for low‑risk pregnant women in China.
-
Using probiotics to prevent gestational diabetes in pregnant women
This study is testing if taking probiotics can help prevent gestational diabetes in pregnant women who are at high risk.
-
Using exhaled carbon monoxide to guide modified care for newborn hemolysis causing severe jaundice
This trial will test whether adding a bedside exhaled-carbon monoxide (ETCOc) measurement to a modified diagnosis and treatment plan can help prevent brain damage in newborns with severe hyperbilirubinemia.
-
A cohort study for patients with Gestational Trophoblastic Neoplasia
This study is gathering information from patients with Gestational Trophoblastic Neoplasia to better understand their treatment and outcomes, including fertility and recurrence rates.
-
Neoadjuvant camrelizumab plus carboplatin/paclitaxel for advanced endometrioid endometrial cancer
This study will test whether adding the PD-1 inhibitor camrelizumab to neoadjuvant carboplatin and paclitaxel helps people with stage III–IV endometrioid endometrial cancer become operable and have better outcomes.
-
Evaluating a fertility-preserving treatment for early-stage endometrial cancer and hyperplasia
This study is testing a new treatment for early-stage endometrial cancer and hyperplasia to see if it can help women of childbearing age preserve their fertility while managing their condition.
-
Understanding Premature Ovarian Insufficiency: Observations from Multiple Hospitals
This study tests how POI develops and affects health by tracking women with POI across several centers.
-
Monitoring metabolic biomarkers in ovarian cancer
This study is trying to find new ways to track ovarian cancer by looking at changes in certain metabolic markers over time to help doctors better tailor treatments for patients.
-
Evaluating the role of end-tidal carbon monoxide in diagnosing and treating ABO hemolytic disease in newborns
This study is testing if measuring carbon monoxide levels in the breath can help doctors better diagnose and treat newborns with ABO hemolytic disease.
-
Exploring cardiovascular health in pregnant women
This study looks at the heart health of pregnant women to see how certain health indicators can affect their pregnancy outcomes.
-
Comparing nab-paclitaxel and solvent-based taxanes for advanced ovarian cancer treatment
This study is testing if a new treatment called nab-paclitaxel, combined with carboplatin, is safer and more effective than standard treatments for people with advanced ovarian cancer.
-
Exploring factors related to cervical and endometrial cancer
This study looks at how different factors like lifestyle and health history might be linked to cervical and endometrial cancers in women aged 20-75 who have been diagnosed with these cancers.
-
Comparing secondary surgery plus chemotherapy to chemotherapy alone for relapsed ovarian cancer after PARPi treatment
This study is testing whether adding surgery to chemotherapy helps women with relapsed ovarian cancer feel better compared to just getting chemotherapy alone after they've been on a specific treatment.
-
Personalized treatment for endometrial cancer based on genetic profiling
This study is testing if using genetic information can help doctors choose the best follow-up treatment for women with certain types of endometrial cancer to lower the chance of the cancer coming back.
-
Combining Fuzuloparib and Arsenic Trioxide for Ovarian Cancer Treatment
This study is testing a new combination of two drugs, Fuzuloparib and Arsenic trioxide, to see if it can help people with ovarian cancer who haven't responded to other treatments.
-
Treatment options for hydatidiform mole with lung nodules
This study is testing different treatment options for patients with hydatidiform mole and lung nodules to see which approach works best for getting their hormone levels back to normal.
-
Hysteroscopic Repeat Curettage as First-Line Treatment for Low-Risk Postmolar GTN
This study tests whether hysteroscopic repeat curettage can be a first-line option for low-risk postmolar GTN, compared with methotrexate chemotherapy.
Quick answers
How many clinical trials run by Women's Hospital School Of Medicine Zhejiang University are recruiting right now?
24, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (24 trials), Rwanda (1 trial), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1, Early Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.